Skip to content
  • Tuesday, 27 October 2026
  • 11:31 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Yale Researchers Uncover Molecular Mechanism Preventing Fertilization Offering New Paths for Infertility Treatment and Contraceptive Development
Stem Cell & Regenerative Medicine

Yale Researchers Uncover Molecular Mechanism Preventing Fertilization Offering New Paths for Infertility Treatment and Contraceptive Development

Dwi Wanna Jun 19, 2026 0

A multi-institutional research team, led by scientists at Yale University, has successfully decoded the molecular architecture of a biological mechanism…

Read More
Stem Cell & Regenerative Medicine

Michigan State University Researchers Identify Molecular Switch Boosting Sperm Energy for Fertilization and Contraceptive Potential

Dwi Wanna Jun 14, 2026 0

In a significant advancement for reproductive biology, a team of researchers at Michigan State University has successfully identified a molecular…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis

Dwi Wanna Jun 6, 2026 0

In a landmark achievement for reproductive science, researchers at Cornell University have announced a significant advancement in the pursuit of…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify New Pathway for Reversible Nonhormonal Male Contraceptive Targeting Meiosis

Dwi Wanna Jun 5, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for…

Read More
Pharmaceutical R&D

Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials

Teuku Ryan Jun 3, 2026 0

Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Develop Breakthrough Reversible Nonhormonal Male Contraceptive Through Targeted Meiotic Disruption

Dwi Wanna May 22, 2026 0

In a significant advancement for reproductive medicine, a team of researchers at Cornell University has announced a major breakthrough in…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Achieve Milestone in Developing Reversible Nonhormonal Male Contraceptive Targeting Meiosis

Dwi Wanna May 14, 2026 0

The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…

Read More
Stem Cell & Regenerative Medicine

Discovery of Protein Interaction Regulating Sperm Morphogenesis Offers New Insights into Male Infertility and Contraceptive Development

Dwi Wanna May 14, 2026 0

The human biological system relies upon a sophisticated architecture of checks and balances to ensure the precise growth, maturation, and…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Potential Pathway for Reversible Non-Hormonal Male Contraceptive Targeting Meiosis

Dwi Wanna May 7, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for a safe, reversible,…

Read More
Stem Cell & Regenerative Medicine

Cornell University scientists develop a safe reversible and long-acting nonhormonal male contraceptive through targeted meiotic disruption

Dwi Wanna Apr 30, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for nonhormonal male contraception…

Read More

Posts pagination

1 2 3
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical LabsCoordinated Molecular and Physiological Adaptations Enable Activity at Subfreezing Temperatures in the Snow Fly Chionea alexandrianaUnderstanding Osteopenia: The Global Silent Epidemic of Bone Density Loss and the Path to PreventionSwapping polluting gas stoves for electric ones reduced asthma symptoms, a study finds
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ